Trial Profile
An open-label, crossover study of liraglutide in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Dec 2016 New trial record